Avanos Medical (AVNS) Raw Materials (2014 - 2026)

Avanos Medical has disclosed Raw Materials across 13 years of filings, most recently posting $4.0 million for Q1 2026.

• Raw Materials for Q1 2026 came in at $4.0 million, down 89.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.0 million (down 89.3% YoY), and the FY2025 annual result was $4.1 million, up 41.38% from the prior year.
• Raw Materials came in at $4.0 million for Q1 2026 at Avanos Medical, down from $4.1 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $57.0 million in Q1 2023 to a low of $2.9 million in Q4 2024.
• The 5-year median for Raw Materials is $36.7 million (2022), against an average of $27.0 million.
• Peak annual rise in Raw Materials reached 1403.03% in 2024, while the deepest fall reached 94.23% in 2024.
• Avanos Medical's Raw Materials stood at $36.7 million in 2022, then soared by 37.06% to $50.3 million in 2023, then tumbled by 94.23% to $2.9 million in 2024, then soared by 41.38% to $4.1 million in 2025, then decreased by 2.44% to $4.0 million in 2026.
• The last three Raw Materials figures came in at $4.0 million (Q1 2026), $4.1 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.